{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-260160","form_type":"8-K","ticker":"OFIX","cik":"0000884624","company_name":"Orthofix Medical Inc.","filed_at":"2022-10-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:53.854778+00:00","generated_at":"2026-06-23T04:36:45.507770+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Orthofix reports Q3 preliminary net sales $114M, up 5% CC; announces SeaSpine merger","bullets":["Preliminary Q3 net sales $114M, +1% reported, +5% constant currency YoY; nine-month net sales $339M, flat reported.","Global Orthopedics grew 19% CC; Biologics +8% CC; Bone Growth Therapies +3% CC; Spinal Implants -7% CC.","Preliminary cash, cash equivalents and restricted cash ~$52M as of Sep 30, 2022.","Entered all-stock merger of equals with SeaSpine (NASDAQ: SPNE) to create leading spine and orthopedics company."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-260160","json":"https://secwatch.observer/filing/0001193125-22-260160.json","markdown":"https://secwatch.observer/filing/0001193125-22-260160.md","text":"https://secwatch.observer/filing/0001193125-22-260160.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/884624/000119312522260160/0001193125-22-260160-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/884624/000119312522260160/d407558d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T04:36:45.507770+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}